Peroxisome Proliferator-Activated Receptors (PPAR): A Potential Strategy to Combat Lipotoxic Heart Disease
By: Qi Tian and Philip M. Barger
Authors
Qi Tian
From Winters Center for Heart Failure Research, Baylor College of Medicine and Texas Heart Institute, St Luke's Episcopal Hospital, Houston, Texas
Philip M. Barger
From Winters Center for Heart Failure Research, Baylor College of Medicine and Texas Heart Institute, St Luke's Episcopal Hospital, Houston, Texas
DOI: https://doi.org/10.14797/mdcvj.80 | Journal eISSN: 1947-6108
Language: English
Page range: 22 - 24
Published on: Jan 1, 2006
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services
© 2006 Qi Tian, Philip M. Barger, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.